Evidence map›Paper›PMID 34961911›Full record

ArticlePharmacoEconomics - open2022

Cost Effectiveness of Digital Interventions for Generalised Anxiety Disorder: A Model-Based Analysis.

Dina Jankovic, Pedro Saramago Goncalves, Lina Gega, David Marshall, Kath Wright, Meena Hafidh, Rachel Churchill, Laura Bojke

Open access · goldAbstract read
In one paragraph

Article in PharmacoEconomics - open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Digital interventions in mental health: evidence syntheses and economic modelling.Health technology assessment (Winchester, England) · 2022
    Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dina JankovicCentre for Health Economics, The University of York, York, YO10 5DD, UK. dina.jankovic@york.ac.uk.ORCID http://orcid.org/0000-0002-9311-1409
Pedro Saramago GoncalvesCentre for Health Economics, The University of York, York, YO10 5DD, UK.ORCID http://orcid.org/0000-0001-9063-8590
Lina GegaDepartment of Health Sciences and Hull York Medical School, University of York, York, UK.ORCID http://orcid.org/0000-0003-2902-9256
David MarshallCentre for Reviews and Dissemination, University of York, York, UK.ORCID http://orcid.org/0000-0001-5969-9539
Kath WrightCentre for Reviews and Dissemination, University of York, York, UK.ORCID http://orcid.org/0000-0002-9020-1572
Meena HafidhCentre for Health Economics, The University of York, York, YO10 5DD, UK.
Rachel ChurchillCentre for Reviews and Dissemination, University of York, York, UK.ORCID http://orcid.org/0000-0002-1751-0512
Laura BojkeCentre for Health Economics, The University of York, York, YO10 5DD, UK.ORCID http://orcid.org/0000-0001-7921-9109
University of York · GB

Funding

National Institute for Health Research 17/93/06National Institute for Health Research 2019
6 · The paper itself

Abstract

backgroundDigital interventions (DIs) are increasingly being used in mental health care, despite limited evidence regarding their value for money. This study aimed to evaluate the cost effectiveness of DIs for generalised anxiety disorder (GAD), in comparison with alternative care options, from the perspective of the UK health care system.

methodsAn open-source decision analytic cohort model was used to extrapolate the results of a network meta-analysis over a patient's lifetime and estimate the costs and outcomes (quality-adjusted life-years) of DIs and their comparators. The net monetary benefit (NMB) and probability of cost effectiveness was estimated for each comparator, and we conducted a Value of Information analysis to evaluate the scale and drivers of uncertainty.

resultsDIs were associated with lower NMB compared with medication and with group therapy, but greater NMB compared with non-therapeutic controls and with usual care. DIs that were supported by a clinician, an assistant or a lay person had higher delivery costs than purely patient-self-directed DIs, yielding a greater NMB when opportunity cost was above £3000/QALY. There was considerable uncertainty in the findings driven largely by uncertainty in the estimated treatment effects. The value of further research to establish the effectiveness of DIs for GAD was substantial, at least £12.9 billion.

conclusionsThe high uncertainty about these results does not allow for recommendations based on the cost effectiveness of DIs. However, the analysis highlights areas for future research, and demonstrates that apparent cost savings associated with DIs can be offset by reduced effectiveness.

Identifiers

PMID34961911
PMCPMC8711685
OpenAlexW4200429132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.